Small-Molecule Ligands of Methyl-Lysine Binding Proteins

被引:88
作者
Herold, J. Martin [1 ]
Wigle, Tim J. [1 ]
Norris, Jacqueline L. [1 ]
Lam, Robert [2 ]
Korboukh, Victoria K. [1 ]
Gao, Cen [1 ]
Ingerman, Lindsey A. [1 ]
Kireev, Dmitri B. [1 ]
Senisterra, Guillermo [2 ]
Vedadi, Masoud [2 ]
Tripathy, Ashutosh [3 ]
Brown, Peter J. [2 ]
Arrowsmith, Cheryl H. [2 ]
Jin, Jian [1 ]
Janzen, William P. [1 ]
Frye, Stephen V. [1 ]
机构
[1] Univ N Carolina, Div Med Chem & Nat Prod, UNC Eshelman Sch Pharm, Ctr Integrated Chem Biol & Drug Discovery, Chapel Hill, NC 27599 USA
[2] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada
[3] Univ N Carolina, Dept Biochem & Biophys, UNC Macromol Interact Facil, Chapel Hill, NC 27599 USA
基金
加拿大创新基金会; 英国惠康基金;
关键词
HISTONE H3; TRANSCRIPTIONAL REPRESSOR; L3MBTL1; RECOGNITION; ANTAGONISTS; INHIBITORS; PROMOTES; TAIL;
D O I
10.1021/jm200045v
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Proteins which bind methylated lysines ("readers" of the histone code) are important components in the epigenetic regulation of gene expression and can also modulate other proteins that contain methyl-lysine such as p53 and Rb. Recognition of methyl-lysine marks by MBT domains leads to compaction of chromatin and a repressed transcriptional state. Antagonists of MBT domains would serve as probes to interrogate the functional role of these proteins and initiate the chemical biology of methyl-lysine readers as a target class. Small-molecule MBT antagonists were designed based on the structure of histone peptide - MBT complexes and their interaction with MBT domains determined using a chemiluminescent assay and ITC. The ligands discovered antagonize native histone peptide binding, exhibiting 5-fold stronger binding affinity to L3MBTL1 than its preferred histone peptide. The first cocrystal structure of a small molecule bound to L3MBTL1 was determined and provides new insights into binding requirements for further ligand design.
引用
收藏
页码:2504 / 2511
页数:8
相关论文
共 42 条
[1]   Structure and function of histone methylation binding proteins [J].
Adams-Cioaba, Melanie A. ;
Min, Jinrong .
BIOCHEMISTRY AND CELL BIOLOGY, 2009, 87 (01) :93-105
[2]   Loss, mutation and deregulation of L3MBTL4 in breast cancers [J].
Addou-Klouche, Lynda ;
Adelaide, Jose ;
Finetti, Pascal ;
Cervera, Nathalie ;
Ferrari, Anthony ;
Bekhouche, Ismahane ;
Sircoulomb, Fabrice ;
Sotiriou, Christos ;
Viens, Patrice ;
Moulessehoul, Soraya ;
Bertucci, Francois ;
Birnbaum, Daniel ;
Chaffanet, Max .
MOLECULAR CANCER, 2010, 9
[3]   THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY [J].
BAILEY, S .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 :760-763
[4]   An operational definition of epigenetics [J].
Berger, Shelley L. ;
Kouzarides, Tony ;
Shiekhattar, Ramin ;
Shilatifard, Ali .
GENES & DEVELOPMENT, 2009, 23 (07) :781-783
[5]   The mammalian epigenome [J].
Bernstein, Bradley E. ;
Meissner, Alexander ;
Lander, Eric S. .
CELL, 2007, 128 (04) :669-681
[6]   The human L(3)MBT polycomb group protein is a transcriptional repressor and interacts physically and functionally with TEL (ETV6) [J].
Boccuni, P ;
MacGrogan, D ;
Scandura, JM ;
Nimer, SD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (17) :15412-15420
[7]   MBT domain proteins in development and disease [J].
Bonasio, Roberto ;
Lecona, Emilio ;
Reinberg, Danny .
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2010, 21 (02) :221-230
[8]   Finding Inspiration in the Protein Data Bank to Chemically Antagonize Readers of the Histone Code [J].
Campagna-Slater, Valerie ;
Schapira, Matthieu .
MOLECULAR INFORMATICS, 2010, 29 (04) :322-331
[9]   Protein methyltransferases as a target class for drug discovery [J].
Copeland, Robert A. ;
Solomon, Michael E. ;
Richon, Victoria M. .
NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (09) :724-732
[10]  
DeLano W.L., 2002, The PyMOL molecular graphics system